---
$id: https://graph.org.ai/products/commodity/51142523
$type: Product
source: UNSPSC
code: "51142523"
title: "Diprobutine"
class: "51142500"
classTitle: "Antiparkinson drugs"
family: "51140000"
familyTitle: "Central nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Diprobutine

**UNSPSC Code**: 51142523
**Class**: [Antiparkinson drugs](Antiparkinson drugs.mdx)
**Family**: [Central nervous system drugs](../Central nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiparkinsonian agent with the molecular formula C10H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5XE7IWD0JX, chemically known as 1,1-dipropylbutylamine but generally known as diprobutine, which bears US NIH Compound Identifier 41701. European Medicines Agency schedules Diprobutine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07221MIG. The term DIPROBUTINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). DIPROBUTINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule diprobutine under HS 29211980 and SITC 51451. As of Q4 2014, DIPROBUTINE remains the US FDA Preferred Term for this commodity. Diprobutine bears US NLM identifiers UMLS ID C0058421 and NCI Concept Code C65430. SMILES: CCCC(CCC)(CCC)N.

